BRCA1 and breast neoplasm: Analysis of Brca1-deficient breast tumors from NVB-treated mice demonstrated significant upregulation of PD-L1 expression by immunohistochemistry (IHC) (Fig. 1e) and by flow cytometry (Fig. 1h; Supplementary Fig. 1g, h).